lemzoparlimab,azacitidine
abbvie,i-mab
['lemzoparlimab', 'azacitidine,(-oral azaci),(-azacitidine oral)', '$imab']
i-mab announces positive phase 2 data of lemzoparlimab in combination with azacitidine in patients with higher risk myelodysplastic syndrome at esmo.. $imab 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice